Synapse - Mark Kris

Results (223)

Export to EndNote / Excel | PubMed

Response to EGFR TKIs in never smokers with stage IV EGFR mutant squamous cell carcinoma of the lung (SQCC)

Meeting Abstract

Paik, P. K.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Incorporation of crizotinib into the NCCN guidelines

Journal Article

Riely, G. J.; Chaft, J. E.; Ladanyi, M.; Kris, M. G.
Journal of the National Comprehensive Cancer Network (2011)

Fulltext@MSK | Save

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib

Journal Article

Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Comprehensive analysis for clinically relevant oncogenic driver mutations in 1131 consecutive lung adenocarcinomas

Meeting Abstract

Arcila, M. E.; Lau, C.; Jhanwar, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Modern Pathology (2011)

Fulltext@MSK | Save

Comprehensive analysis for clinically relevant oncogenic driver mutations in 1131 consecutive lung adenocarcinomas

Meeting Abstract

Arcila, M. E.; Lau, C.; Jhanwar, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Laboratory Investigation (2011)

Fulltext@MSK | Save

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling

Journal Article

Chmielecki, J.; Foo, J.; Oxnard, G. R.; Hutchinson, K.; Ohashi, K.; Somwar, R.; Wang, L.; Amato, K. R.; Arcila, M.; Sos, M. L.; more...
Science Translational Medicine (2011)

Fulltext@MSK | Save

Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene

Journal Article

Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

Journal Article

Paik, P. K.; Arcila, M. E.; Fara, M.; Sima, C. S.; Miller, V. A.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation

Journal Article

Oxnard, G. R.; Arcila, M. E.; Sima, C. S.; Riely, G. J.; Chmielecki, J.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations

Journal Article

Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save